Paper
Epidemiology and clinical features of Mycoplasma pneumoniae infection in children.
Published Dec 1, 2008 · A. Defilippi, M. Silvestri, A. Tacchella
Respiratory medicine
Q1 SJR score
146
Citations
15
Influential Citations
Abstract
Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Observational Study
Highly CitedStudy Snapshot
Mycoplasma pneumoniae infection is common in preschool-aged children, including young infants, and may present differently than in older children.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
Sign up to use Study Snapshot
Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.
Full text analysis coming soon...
References
Development and clinical validation of a real-time PCR using a uni-molecular Scorpion-based probe for the detection of Mycoplasma pneumoniae in clinical isolates.
The Scorpion-probe real-time PCR assay offers faster performance and sensitivity for detecting Mycoplasma pneumoniae in clinical isolates, making it more sensitive than traditional qualitative PCR methods.
2007·18citations·E. di Marco et al.·The new microbiologica
The new microbiologica
New concepts of Mycoplasma pneumoniae infections in children
Mycoplasma pneumoniae infections in children and adults are now more common and complex, with molecular tests revealing new insights into their biology and epidemiology.
2003·163citations·K. Waites·Pediatric Pulmonology
Pediatric Pulmonology
Prevalence of Mycoplasma pneumoniae in children in Diyarbakir, the south‐east of Turkey
Mycoplasma pneumoniae seroprevalence in children aged 0-14 years in Diyarbakir is 1.3%, with varying infection prevalence in different age groups.
2002·21citations·M. Boşnak et al.·Pediatrics International
Pediatrics International
Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired lower respiratory tract infections.
Mycoplasma pneumoniae and Chlamydia pneumoniae play a significant role in community-acquired lower respiratory tract infections in children, and inadequate treatment can lead to more complicated infections and longer hospitalizations.
2001·272citations·N. Principi et al.·Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Diagnosis of Mycoplasma pneumoniaePneumonia in Children
The IgM serology test is the most valuable tool for diagnosing Mycoplasma pneumoniae pneumonia in children of any age, with sensitivity increasing to 95% when combined with PCR and Southern hybridization.
1998·162citations·M. Waris et al.·Journal of Clinical Microbiology
Journal of Clinical Microbiology
Community outbreak of acute respiratory infection by Mycoplasma pneumoniae
Mycoplasma pneumoniae infection is highly prevalent in children under 5, highlighting the need for early and appropriate treatment in these cases.
1996·19citations·Á. Domínguez et al.·European Journal of Epidemiology
European Journal of Epidemiology
Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate.
Clarithromycin and erythromycin are similarly effective and safe for treating radiographically proven, community-acquired pneumonia in children aged 3-12 years.
1995·329citations·S. Block et al.·The Pediatric infectious disease journal
The Pediatric infectious disease journal
Experience with newer techniques for the laboratory detection of Mycoplasma pneumoniae infection: Adelaide, 1978-1992.
Newer laboratory methods for detecting Mycoplasma pneumoniae infection, such as cell-sheet culture and indirect hemagglutination, have improved diagnostic sensitivity and rapidity.
1993·48citations·B. Marmion et al.·Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Citations
Mycoplasma pneumoniae among children hospitalized in a tertiary hospital with community- acquired lower respiratory tract infections.
Mycoplasma pneumoniae infection plays a critical role in community-acquired lower respiratory tract infections in children, particularly in those under five years old, and is associated with wheezing.
2024·0citations·Surinder Kumar et al.·Indian journal of medical microbiology
Indian journal of medical microbiology
Mycoplasma myocarditis presenting with sustained SVT and acute heart failure without signs of myocardiocytolysis and extra‐cardiac disease
Mycoplasma myocarditis is a rare but potentially serious condition that can cause heart muscle inflammation and lead to arrhythmia and heart failure in young patients, even without signs of myocardiocytolysis and extra-cardiac disease.
2024·0citations·M. Radaelli et al.·Clinical Case Reports
Clinical Case Reports
Epidemiology of Mycoplasma pneumoniae in children with acute respiratory infections in Hangzhou during January 2021 to June 2023
The positivity rate of Mycoplasma pneumoniae in children increased significantly after COVID-19 adjustments in China, with the most significant increase in infants under 1 year of age.
2024·1citation·Lin Chen et al.·Journal of Laboratory Medicine
Journal of Laboratory Medicine
Mycoplasma pneumoniae Infection Among Children: A Systematic Review and Meta-analysis of Published Literature
The global rate of Mycoplasma pneumoniae infection in children has been gradually increasing since 2001, with the highest prevalence in children aged 10-18 years.
2023·0citations·Bahareh Hajikhani et al.·International Journal of Enteric Pathogens
International Journal of Enteric Pathogens
Detection of Mycoplasma pneumoniae in hospitalized children with pneumonia in Laos
Enhancing diagnostic systems for Mycoplasma pneumoniae detection and analyzing its antibiotic resistance profile is needed to improve awareness, raise awareness, and enable targeted therapy and inform treatment guidelines in Laos.
2023·0citations·Keoudomphone Vilivong et al.·Wellcome Open Research
Wellcome Open Research
Establishment and Performance Evaluation of Multiplex PCR-Dipstick DNA Chromatography for Mycoplasma pneumoniae and Chlamydia pneumoniae Rapid Detection
A multiplex PCR-dipstick chromatography assay effectively detects Mycoplasma pneumoniae and Chlamydia pneumoniae within 2 hours, offering simple, fast, sensitive, accurate, and cost-effective diagnostic performance for small laboratories and point-of-care diagnosis.
2023·0citations·Liuyang Hu et al.·The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien des Maladies Infectieuses et de la Microbiologie Médicale
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien des Maladies Infectieuses et de la Microbiologie Médicale